|~ SEND US YOUR QUESTIONS ABOUT LUNG CANCER ~|
Lung cancer is the second-most diagnosed cancer among both men and women. Smoking significantly increases a person's chance of developing the disease, but people who have never smoked may develop lung cancer, too. According to the National Cancer Institute, one out of every 14 Americans will be diagnosed with lung or airway cancer in their lifetime. This web chat will focus on different options for the treatment of lung cancer, as well as new and innovative technologies focused on lung cancer treatment.
At Cancer Treatment Centers of America (CTCA), we believe there isn't one way to beat cancer - there are hundreds. For nearly 30 years, we've been committed to finding the right combination of personalized cancer treatments for our patients.
Together with you and your caregivers, we develop an integrated treatment plan that's right for you. A dedicated team of oncologists, surgeons and other specialists deliver advanced cancer treatment - including safer, more effective radiation therapy; new targeted drug therapies; and minimally invasive surgical alternatives. At the same time, we support you with therapies to boost your immune system, reduce pain and improve quality of life.
Our national network of fully-accredited hospitals earned the Full Standards Compliance from the Joint Commission. Each hospital provides state-of-the-art cancer care in a welcoming environment, where you and your family can focus on healing.
At CTCA, we never give up. We give you advanced treatment options, so you can take control of the disease.
David L. Topolsky, MD
Hematologist-Oncologist & Medical Oncologist
Dr. David Topolsky believes empowering patients to make educated decisions about their treatment is a critical part of his role as an oncologist. He says, "I empower my patients by giving them the knowledge to make treatment decisions they feel are best for them."
In July 2011, Dr. Topolsky became a member of our integrated team of cancer experts at our Philadelphia hospital, Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center. The seasoned medical oncologist brings nearly 30 years of experience to his position at CTCA.
Dr. Topolsky is board certified in hematology, medical oncology and internal medicine. After receiving a bachelor's degree from Temple University, he earned a medical degree from Hahnemann University in Philadelphia. He then completed an internship and residency in internal medicine, as well as a hematology-oncology fellowship at Hahnemann University. He also served as Chief Fellow.
For several years, Dr. Topolsky was an associate professor of hematology-oncology at Drexel University College of Medicine/Hahnemann University Hospital in Philadelphia. While with the university hospital, he served as medical director of its national marrow donor transplant center and as co-medical director of its stem cell processing lab.
Dr. Topolsky has been published extensively. His research has been published in leading clinical journals, such as the American Journal of Clinical Oncology and the American Journal of Hematology.
He is a member of a number of professional associations, including the American Society of Hematology, American Society of Clinical Oncology, American Society for Blood and Marrow Transplantation, and the American Medical Association.